Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by VoxSolison Nov 08, 2017 9:17am

177 Views

Post# 26924117

RE:RE:RE:RE:RE:RE:Retreatment Possible Equals More Revenue

Vestor; exactly. Current gold standard treatment had failed to further help patients in this trial. Any safe improvement in treatment/extension of life is of immense benefit. There is also great promise in treatment of patients whose cancer has not advanced as far as patients in current trials, which these results will pave the way for. Long & not worried.

Bullboard Posts

Morning Market Outlook for Nov. 14, 2024